Africa

The epidemic may be nearing “zero cases” — but it's still disrupting the delivery of vaccines for measles, polio, and other deadly childhood diseases.

FOREIGN POLICY                                                                                                    April 27, 2015

by Ellen Johnson Sirleaf, President of Liberia, and Seth Berkley,  President and CEO of the Gavi vaccine alliance

When the Ebola epidemic in West Africa comes to an end, it will be marked by two simple words: “zero cases.” But this momentous milestone will also signal the beginning of a new struggle as the long and difficult process of recovering from a crisis that has claimed more than 10,000 lives commences. Ebola has not only drawn attention to the vast gap that exists between rich and poor nations; it has widened that divide too, setting the people of Liberia, Sierra Leone, and Guinea even further back. The opportunity to narrow and ultimately close this gap cannot be neglected.

BUSINESS STANDARD                                                                        April 27, 2015

HYDERABAD, India --Ella Foundation, which has taken up research for finding a potential vaccine for the deadly Ebola virus, today said it had successfully completed preliminary studies on the virus, which was responsible for high fatalities among humans in central Africa.

The Hyderabad-based foundation said it had completed the preliminary animal (with mice) experiments of the virus' glycoprotein with the targeted adenovirus, and the "immune response results have been good", which would be followed by toxicology tests and the subsequent clinical trials involving human beings.

Adenoviruses are responsible for respiratory infections, gastroenteritis, cystitis, and primary pneumonia in humans, and are therefore used as a clear target to understand the human immunity characteristics in laboratory. However, the efficacy of the vaccine is judged by the outcomes seen in human trials.

Read complete story.

http://www.business-standard.com/article/current-affairs/ella-foundation-announces-key-outcomes-in-ebola-vaccine-research-115042700631_1.html

AFP    by Zoom Dosso                                                            April 24, 2015
Monrovia -- As the Ebola epidemic retreats across west Africa, international health authorities are turning their attention to the little understood long-term effects of the often-deadly virus on the survivors.

Matshidiso Moeti, the WHO's new head in Africa, told AFP that Liberian survivors had been reporting a range of problems, including sight and hearing impairment.

"We need to be aware that (complications) may be occurring and pay attention when people are being treated in case there is something that can be done to help them," she told AFP in the Liberian capital Monrovia.

Read complete story.

http://news.yahoo.com/west-africa-battles-mystery-post-ebola-syndrome-034727521.html;_ylt=AwrC0CM1rDtVtDoA83rQtDMD;_ylu=X3oDMTByOHZyb21tBGNvbG8DYmYxBHBvcwMxBHZ0aWQDBHNlYwNzcg--

AFP                                                                                                             April 24, 2015
PARIS --The collapse of health services in three west African countries devastated by Ebola may have caused some 11,000 additional deaths from malaria, a preventable and curable disease, researchers said Friday.

Desinfected gloves dry at Elwa hospital in Monrovia, Liberia on September 7, 2014 (AFP Photo/Dominique Faget)

A further 3,900 deaths may have resulted from interruptions in the delivery of insecticide-treated bed nets, according to outbreak modelling data published in The Lancet on the eve of World Malaria Day.

This suggested the haemorrhagic fever outbreak "could have resulted in a comparable number of malaria deaths as those due to Ebola itself," said a statement issued by the medical journal.

Read full story.